Pancreatic cancer ca 19 9 antigen. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy15

Cell Line, Tumor Pancreas Tumor Cells, Cultured Cell Line T-Lymphocytes Pancreatic Ducts Neoplastic Stem Cells Pancreatic Stellate Cells Cells, Cultured Pancreatic Juice CA1 Region, Hippocampal Lymph Nodes Immune Sera CA3 Region, Hippocampal B-Lymphocytes

Organisms7

Mice, Nude Mice, Inbred BALB C Mice, SCID Mice, Inbred C57BL Rabbits Mice, Transgenic Adenoviridae

Diseases33

Pancreatic Neoplasms Carcinoma, Pancreatic Ductal Adenocarcinoma Neoplasm Invasiveness Neoplasm Metastasis Prostatic Neoplasms Ovarian Neoplasms Lung Neoplasms Colonic Neoplasms Breast Neoplasms Neoplasms Disease Progression Stomach Neoplasms Pancreatitis Genetic Predisposition to Disease Pancreatitis, Chronic Carcinoma Cell Transformation, Neoplastic Neovascularization, Pathologic Liver Neoplasms Disease Models, Animal Colorectal Neoplasms Uterine Cervical Neoplasms Carcinoma, Squamous Cell Neoplasm Recurrence, Local Urinary Bladder Neoplasms Precancerous Conditions Carcinoma, Non-Small-Cell Lung Rectal Neoplasms Gastrointestinal Neoplasms Neoplasms, Experimental Melanoma Carcinoma in Situ

Chemicals and Drugs90

Antigens Antigens, Neoplasm Antigens, Bacterial Antigens, Surface Deoxycytidine Antigens, Viral CA-19-9 Antigen Antimetabolites, Antineoplastic Carcinoembryonic Antigen Antigens, Protozoan Tumor Markers, Biological Antibodies, Monoclonal Antigens, Polyomavirus Transforming Antigens, CD Antigens, Tumor-Associated, Carbohydrate Antineoplastic Agents HLA Antigens Neoplasm Proteins Prostate-Specific Antigen RNA, Messenger Antigens, Fungal Antigens, Helminth H-2 Antigens Cancer Vaccines RNA, Small Interfering Proliferating Cell Nuclear Antigen Antigens, Viral, Tumor Receptors, Antigen, T-Cell HLA-DR Antigens Fluorouracil Epitopes Histocompatibility Antigens Histocompatibility Antigens Class II Receptors, Antigen, B-Cell HLA-A2 Antigen O Antigens Antigens, CD15 DNA, Neoplasm Immunoglobulin G Antigens, CD8 Tumor Suppressor Protein p53 Antigens, CD3 Mucin-1 Ca(2+) Mg(2+)-ATPase HLA-A Antigens Hepatitis B Surface Antigens Blood Group Antigens CA-125 Antigen Membrane Proteins Recombinant Proteins Proto-Oncogene Proteins Histocompatibility Antigens Class I MicroRNAs Smad4 Protein Receptor, Epidermal Growth Factor Enzyme Inhibitors Ki-67 Antigen Calcium Cisplatin Mucin-4 Receptor, erbB-2 DNA-Binding Proteins Peptides RNA, Neoplasm Antineoplastic Agents, Phytogenic Receptors, Antigen Receptors, Estrogen Antigens, CD45 Protein Kinase Inhibitors HLA-D Antigens Nuclear Proteins Antibodies Antigens, CD4 Hepatitis B Antigens DNA Primers Antibodies, Bacterial Tumor Suppressor Proteins Proto-Oncogene Proteins c-akt Anticarcinogenic Agents ras Proteins Quinazolines ABO Blood-Group System Immune Sera Antigens, CD1 Antigens, Differentiation Transcription Factors GPI-Linked Proteins Antigens, CD24 HLA-B Antigens Glycoproteins

Analytical, Diagnostic and Therapeutic Techniques and Equipment62

Early Detection of Cancer Xenograft Model Antitumor Assays Reverse Transcriptase Polymerase Chain Reaction Blotting, Western Neoplasm Transplantation Prognosis Immunohistochemistry Antineoplastic Combined Chemotherapy Protocols Survival Analysis Survival Rate Enzyme-Linked Immunosorbent Assay Transplantation, Heterologous Immunoenzyme Techniques Sensitivity and Specificity Neoplasm Staging Risk Factors Combined Modality Therapy Gene Expression Profiling Pancreatectomy Flow Cytometry Prospective Studies Retrospective Studies Transfection Tumor Burden Risk Polymerase Chain Reaction Fluorescent Antibody Technique Follow-Up Studies Treatment Outcome Odds Ratio Risk Assessment Disease Models, Animal Oligonucleotide Array Sequence Analysis Disease-Free Survival Kaplan-Meier Estimate Registries Chemotherapy, Adjuvant Palliative Care Drug Screening Assays, Antitumor Lymphocyte Activation Models, Biological Gene Knockdown Techniques Pancreaticoduodenectomy Multivariate Analysis Immunoblotting Tissue Array Analysis Molecular Targeted Therapy Predictive Value of Tests Clinical Trials as Topic Case-Control Studies Reproducibility of Results Endosonography Incidence SEER Program Genetic Therapy Neoplasms, Experimental Cohort Studies Questionnaires Immunization Drug Delivery Systems Logistic Models DNA Mutational Analysis

Psychiatry and Psychology1

Phenomena and Processes46

Gene Expression Regulation, Neoplastic Cell Proliferation Apoptosis Signal Transduction Drug Resistance, Neoplasm Mutation Genetic Predisposition to Disease Sensitivity and Specificity Cell Survival Cell Movement Cell Division Dose-Response Relationship, Drug Transfection Time Factors Cell Growth Processes Base Sequence Down-Regulation Amino Acid Sequence Risk Up-Regulation RNA Interference Genes, ras Phosphorylation Cell Cycle Odds Ratio Gene Expression Antibody Specificity Drug Synergism Cross Reactions Genotype Gene Silencing Lymphocyte Activation Phenotype DNA Methylation Promoter Regions, Genetic Epithelial-Mesenchymal Transition Protein Binding Genes, Neoplasm Germ-Line Mutation Antigen-Antibody Reactions Antibody Formation Polymorphism, Genetic Genes, Tumor Suppressor Genetic Vectors Genes, BRCA1 Enzyme Activation

Disciplines and Occupations2

Immunohistochemistry Medical Oncology

Anthropology, Education, Sociology and Social Phenomena1

National Cancer Institute (U.S.)

Information Science8

Molecular Sequence Data Survival Rate Base Sequence Amino Acid Sequence Registries Incidence SEER Program Questionnaires

Named Groups1

Health Care28

Survival Analysis Survival Rate Sensitivity and Specificity Risk Factors Prospective Studies Retrospective Studies Risk Follow-Up Studies Treatment Outcome Odds Ratio Risk Assessment Disease-Free Survival Kaplan-Meier Estimate Registries Palliative Care Age Factors Multivariate Analysis National Cancer Institute (U.S.)Predictive Value of Tests Clinical Trials as Topic Case-Control Studies Reproducibility of Results Incidence SEER Program Cohort Studies Questionnaires Immunization Logistic Models

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Information Science Health Care Geographicals

Pancreatic Neoplasms Antigens Carcinoma, Pancreatic Ductal Antigens, Neoplasm Antigens, Bacterial Antigens, Surface Cell Line, Tumor Deoxycytidine Antigens, Viral Adenocarcinoma Mice, Nude CA-19-9 Antigen Early Detection of Cancer Gene Expression Regulation, Neoplastic Neoplasm Invasiveness Antimetabolites, Antineoplastic Carcinoembryonic Antigen Xenograft Model Antitumor Assays Antigens, Protozoan Neoplasm Metastasis Tumor Markers, Biological Antibodies, Monoclonal Cell Proliferation Antigens, Polyomavirus Transforming Antigens, CD Antigens, Tumor-Associated, Carbohydrate Antineoplastic Agents HLA Antigens Prostatic Neoplasms Pancreas Reverse Transcriptase Polymerase Chain Reaction Neoplasm Proteins Blotting, Western Prostate-Specific Antigen Tumor Cells, Cultured RNA, Messenger Antigens, Fungal Neoplasm Transplantation Apoptosis Prognosis Immunohistochemistry Ovarian Neoplasms Antigens, Helminth Lung Neoplasms Colonic Neoplasms H-2 Antigens Breast Neoplasms Neoplasms Mice, Inbred BALB C Antineoplastic Combined Chemotherapy Protocols Disease Progression Survival Analysis Molecular Sequence Data Cancer Vaccines Signal Transduction Drug Resistance, Neoplasm Mutation Survival Rate Stomach Neoplasms Pancreatitis RNA, Small Interfering Proliferating Cell Nuclear Antigen Enzyme-Linked Immunosorbent Assay Antigens, Viral, Tumor Transplantation, Heterologous Genetic Predisposition to Disease Immunoenzyme Techniques Sensitivity and Specificity Cell Survival Receptors, Antigen, T-Cell Cell Line Neoplasm Staging Cell Movement Pancreatitis, Chronic HLA-DR Antigens Cell Division Risk Factors Combined Modality Therapy Carcinoma Gene Expression Profiling Pancreatectomy Fluorouracil Dose-Response Relationship, Drug Epitopes Flow Cytometry Prospective Studies Retrospective Studies Transfection Time Factors Cell Growth Processes Tumor Burden Histocompatibility Antigens Base Sequence Down-Regulation Cell Transformation, Neoplastic T-Lymphocytes Amino Acid Sequence Pancreatic Ducts Histocompatibility Antigens Class II Risk

No FAQ available that match "pancreatic cancer ca 19 9 antigen"